| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.32 | 0.05 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.05 |